Different studies of hepatocellular carcinoma, melanoma and acute myeloid leukemia suggest that FAK operates upstream of Wnt, while in prostate cancer Wnt seems to acts upstream of FAK. This evidence concerns the gene PTK2 and hepatocellular carcinoma.